NDTVCenter·
Sun Pharma Plans Rs 10,000 Crore Rupee Debt Sale To Refinance Organon Deal: Report
India's largest drugmaker by market capitalisation is expected to sell bonds with maturities of two, three and four years.
Read at NDTV →
Business · 1 sources covering this
Sun Pharma Plans Rs 10,000 Crore Rupee Debt Sale To Refinance Organon Deal: Report
India's largest drugmaker by market capitalisation is expected to sell bonds with maturities of two, three and four years.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/5254d31a2e9b840e68338a77ed0cddb319eeb96b" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Sun Pharma Plans Rs 10,000 Crore Rupee Debt Sale To Refinance Organon Deal: Report"></iframe>
